Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 3
1990 12
1991 10
1992 8
1993 13
1994 19
1995 23
1996 19
1997 22
1998 24
1999 28
2000 28
2001 27
2002 19
2003 21
2004 30
2005 27
2006 38
2007 34
2008 42
2009 45
2010 52
2011 36
2012 60
2013 70
2014 100
2015 133
2016 151
2017 145
2018 137
2019 177
2020 182
2021 211
2022 197
2023 193
2024 193
2025 236
2026 105

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,546 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: verned
Page 1
Maternal Immunization: Current Evidence, Progress, and Challenges.
Santilli V, Sgrulletti M, Costagliola G, Beni A, Mastrototaro MF, Montin D, Rizzo C, Martire B, Miraglia Del Giudice M, Moschese V; Italian Society of Pediatric Allergy and Immunology (SIAIP) Vaccine Committee. Santilli V, et al. Vaccines (Basel). 2025 Apr 24;13(5):450. doi: 10.3390/vaccines13050450. Vaccines (Basel). 2025. PMID: 40432062 Free PMC article. Review.
We provide an overview of current recommendations and the safety and efficacy profiles of maternal vaccines, including influenza, tetanus-diphtheria-acellular pertussis (Tdap), respiratory syncytial virus (RSV), COVID-19, and hepatitis B. Additionally, we analyze the barri …
We provide an overview of current recommendations and the safety and efficacy profiles of maternal vaccines, including influenza, tetanus-di …
HBV Infection in HIV-Driven Immune Suppression.
Sarmati L, Malagnino V. Sarmati L, et al. Viruses. 2019 Nov 19;11(11):1077. doi: 10.3390/v11111077. Viruses. 2019. PMID: 31752284 Free PMC article. Review.
Worldwide, approximately 10% of all human immunodeficiency virus (HIV)-infected people are also chronically coinfected with hepatitis B virus (HBV). HBV infection has a poor prognosis in HIV-positive people and has been documented by an increased risk of developing chronic …
Worldwide, approximately 10% of all human immunodeficiency virus (HIV)-infected people are also chronically coinfected with hepatitis B …
Cryoglobulins: putative effectors of adaptive immune response.
Basile U, Napodano C, Marino M, Gulli F, Colantuono S, Casato M, Pocino K, Basile V, Todi L, Rapaccini GL, Visentini M. Basile U, et al. Clin Exp Rheumatol. 2021 Mar-Apr;39 Suppl 129(2):171-179. doi: 10.55563/clinexprheumatol/keip4u. Epub 2020 Oct 29. Clin Exp Rheumatol. 2021. PMID: 33124568 Free article. Review.
This is probably due directly to the transformation of infected B cells but, also, indirectly, to the viral chronic stimulation of a pool of autoreactive B cells. The pattern of IgG subclasses seems to contribute to the worsening progression of HCV infection into ly …
This is probably due directly to the transformation of infected B cells but, also, indirectly, to the viral chronic stimulation of a …
CAR-T Therapy Beyond B-Cell Hematological Malignancies.
Canichella M, de Fabritiis P. Canichella M, et al. Cells. 2025 Jan 3;14(1):41. doi: 10.3390/cells14010041. Cells. 2025. PMID: 39791742 Free PMC article. Review.
Despite the advances of CAR-T cells in certain hematological malignancies, mostly from B-cell derivations such as non-Hodgkin lymphomas, acute lymphoblastic leukemia and multiple myeloma, a significant portion of other hematological and non-hematological pathologies can be …
Despite the advances of CAR-T cells in certain hematological malignancies, mostly from B-cell derivations such as non-Hodgkin lymphom …
Fingolimod Immune Effects Beyond Its Sequestration Ability.
Sica F, Centonze D, Buttari F. Sica F, et al. Neurol Ther. 2019 Dec;8(2):231-240. doi: 10.1007/s40120-019-00162-7. Epub 2019 Nov 6. Neurol Ther. 2019. PMID: 31696392 Free PMC article. Review.
Additionally, fingolimod inhibits expression of Th1 and Th17 cytokines and enhances regulatory T-cell differentiation. It also acts on the B arm of immunity through an increased ratio of naive to memory B cells, higher percentage of plasma cells, and highly increase …
Additionally, fingolimod inhibits expression of Th1 and Th17 cytokines and enhances regulatory T-cell differentiation. It also acts on the …
GD3 ganglioside and apoptosis.
Malisan F, Testi R. Malisan F, et al. Biochim Biophys Acta. 2002 Dec 30;1585(2-3):179-87. doi: 10.1016/s1388-1981(02)00339-6. Biochim Biophys Acta. 2002. PMID: 12531552 Review.
2,546 results